Portfolio
Berkshire Hathaway Bet Big on Dialysis Giant DaVita. Jim Chanos Thinks It’s a Scam.
DaVita provides life-extending dialysis treatment to more than 200,000 patients. But is it gaming the system through questionable donations to the American Kidney Fund?
By
Christine Idzelis
December 4, 2019
U.S.
DaVita
William Blair
Jim Chanos
Berkshire Hathaway
